Colchicine alleviates atherosclerosis combined with diabetes mellitus by targeting PIM2 and regulating the NF-κB signaling pathway
- 22 August 2025
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 147, 157194
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7244300)
This publication has 38 references indexed in Scilit:
- Mechanism of Xue-Jie-San treating Crohn's disease complicated by atherosclerosis: Network pharmacology, molecular docking and experimental validationPhytomedicine, 2024
- Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarctionAmerican Heart Journal, 2024
- The burden of cardiovascular disease attributable to high fasting plasma glucose:Findings from the global burden of disease study 2019Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024
- Elevated CD169 expressing monocyte/macrophage promotes systemic inflammation and disease progression in cirrhosisClinical and Experimental Medicine, 2024
- Cluster of Differentiation-44-Targeting Prussian Blue Nanoparticles Onloaded with Colchicine for Atherosclerotic Plaque Regression in a Mice ModelACS Biomaterials Science & Engineering, 2024
- Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart diseaseCell Metabolism, 2021
- AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python BindingsJournal of Chemical Information and Modeling, 2021
- Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trialThe Lancet Diabetes & Endocrinology, 2020
- CD13 deficiency leads to increased oxidative stress and larger atherosclerotic lesionsAtherosclerosis, 2019
- Endothelial to Mesenchymal Transition in Cardiovascular DiseaseJACC, 2019